ICON Public Limited (NASDAQ:ICLR - Free Report) - William Blair cut their Q2 2025 earnings per share (EPS) estimates for ICON Public in a research note issued to investors on Thursday, May 1st. William Blair analyst M. Smock now expects that the medical research company will earn $3.06 per share for the quarter, down from their prior estimate of $3.18. William Blair has a "Outperform" rating on the stock. The consensus estimate for ICON Public's current full-year earnings is $13.38 per share. William Blair also issued estimates for ICON Public's Q3 2025 earnings at $3.17 EPS, Q4 2025 earnings at $3.33 EPS, FY2025 earnings at $12.62 EPS, Q1 2026 earnings at $3.13 EPS, Q2 2026 earnings at $3.27 EPS and Q3 2026 earnings at $3.51 EPS.
A number of other equities research analysts have also issued reports on ICLR. JPMorgan Chase & Co. lowered shares of ICON Public from an "overweight" rating to a "neutral" rating and cut their price objective for the company from $265.00 to $150.00 in a report on Tuesday, April 29th. Citigroup lowered their target price on ICON Public from $290.00 to $215.00 and set a "buy" rating for the company in a research report on Monday, April 7th. TD Cowen cut shares of ICON Public from a "buy" rating to a "hold" rating and reduced their price target for the stock from $254.00 to $157.00 in a research report on Monday, April 14th. Barclays dropped their price objective on shares of ICON Public from $165.00 to $155.00 and set an "equal weight" rating for the company in a research note on Friday. Finally, Truist Financial decreased their target price on shares of ICON Public from $262.00 to $208.00 and set a "buy" rating on the stock in a research report on Thursday, April 10th. Eight research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $215.33.
Read Our Latest Analysis on ICLR
ICON Public Stock Performance
ICLR opened at $142.96 on Monday. ICON Public has a 1-year low of $133.28 and a 1-year high of $347.72. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.26 and a quick ratio of 1.34. The firm has a market cap of $11.55 billion, a P/E ratio of 15.00, a PEG ratio of 1.86 and a beta of 1.23. The company has a 50 day simple moving average of $165.03 and a two-hundred day simple moving average of $194.75.
ICON Public (NASDAQ:ICLR - Get Free Report) last issued its quarterly earnings results on Wednesday, April 30th. The medical research company reported $3.19 earnings per share for the quarter, topping the consensus estimate of $3.17 by $0.02. ICON Public had a net margin of 9.56% and a return on equity of 11.81%. The business had revenue of $2 billion for the quarter, compared to analysts' expectations of $2.03 billion. During the same quarter last year, the company posted $3.47 EPS. The company's revenue was down 4.3% compared to the same quarter last year.
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the stock. Steph & Co. grew its stake in ICON Public by 3.7% in the 4th quarter. Steph & Co. now owns 1,560 shares of the medical research company's stock worth $327,000 after acquiring an additional 55 shares in the last quarter. Private Trust Co. NA increased its holdings in ICON Public by 48.8% during the 4th quarter. Private Trust Co. NA now owns 250 shares of the medical research company's stock worth $52,000 after purchasing an additional 82 shares during the period. Transcend Capital Advisors LLC raised its position in ICON Public by 7.6% during the 1st quarter. Transcend Capital Advisors LLC now owns 1,174 shares of the medical research company's stock valued at $205,000 after purchasing an additional 83 shares in the last quarter. Farther Finance Advisors LLC lifted its holdings in shares of ICON Public by 22.8% in the 1st quarter. Farther Finance Advisors LLC now owns 593 shares of the medical research company's stock worth $99,000 after buying an additional 110 shares during the period. Finally, Sierra Ocean LLC bought a new position in shares of ICON Public during the 4th quarter worth $29,000. 95.61% of the stock is currently owned by institutional investors.
ICON Public Company Profile
(
Get Free Report)
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ICON Public, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICON Public wasn't on the list.
While ICON Public currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
